Evolving Use of ICIs and Targeted Tx in NSCLC and SCLC

In this video,Apar Ganti, MD, highlights recent advances and studies presented at ASCO 2018 on management of NSCLC and SCLC with ICIs and targeted agents.

Source: CancerNetwork - June 9, 2018 Category: Cancer & Oncology Authors: Apar Kishor Ganti, MD, MS Source Type: news